shengmai san
Recently Published Documents


TOTAL DOCUMENTS

47
(FIVE YEARS 2)

H-INDEX

15
(FIVE YEARS 0)

2021 ◽  
Vol 271 ◽  
pp. 113914
Author(s):  
Tzu-Yi Chiang ◽  
Hong-Jaan Wang ◽  
Yen-Cih Wang ◽  
Elise Chia-Hui Tan ◽  
I-Jung Lee ◽  
...  

2021 ◽  
Vol Volume 14 ◽  
pp. 647-657
Author(s):  
Yanting Lu ◽  
Shu Zhu ◽  
Xiaoyan Wang ◽  
Juhai Liu ◽  
Yingying Li ◽  
...  

2020 ◽  
Vol 34 (12) ◽  
pp. 3249-3261
Author(s):  
Ayaz Ahmed ◽  
Guirong Zeng ◽  
Mudassar Azhar ◽  
Haiying Lin ◽  
Mijia Zhang ◽  
...  

2018 ◽  
Vol 50 (5) ◽  
pp. 1726-1739 ◽  
Author(s):  
Jing Tian ◽  
Wenzhu Tang ◽  
Ming Xu ◽  
Chen Zhang ◽  
Pei Zhao ◽  
...  

Background/Aims: Shengmai San (SMS), prepared from Panax ginseng, Ophiopogon japonicus, and Schisandra chinensisin, has been widely used to treat ischemic disease. In this study, we investigated whether SMS may exert a beneficial effect in diabetic cardiomyopathy through improvement of mitochondrial lipid metabolism. Methods: A leptin receptor-deficient db/db mouse model was utilized, and lean age-matched C57BLKS mice served as non-diabetic controls. Glucose and lipid profiles, myocardial structure, dimension, and function, and heart weight to tibial length ratio were determined. Myocardial ultrastructural morphology was observed with transmission electron microscopy. Protein expression and activity of oxidative phosphorylation (OXPHOS) complex were assessed using western blotting and microplate assay kits. We also observed cellular viability, mitochondrial membrane potential, OXPHOS complex activity, and cellular ATP level in palmitic acid-stimulated H9C2 cardiomyocytes. Changes in the sirtuin (SIRT1)/AMP-activated protein kinase (AMPK)/peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) pathway and mitochondrial uncoupling signaling were assessed using western blotting and quantitative real-time PCR. Results: Leptin receptor-deficient db/db mice exhibit obesity, hyperglycemia, and hyperlipidemia, accompanied by distinct myocardial hypertrophy and diastolic dysfunction. SMS at a dose of 3 g/kg body weight contributed to a recovery of diabetes-induced myocardial hypertrophy and diastolic dysfunction. SMS administration led to an effective restoration of mitochondrial structure and function both in vivo and in vitro. Furthermore, SMS markedly enhanced SIRT1 and p-AMPKα protein levels and decreased the expression of acetylated-PGC-1α and uncoupling protein 2 protein. SMS also restored the depletion of NRF1 and TFAM levels in diabetic hearts and H9C2 cardiomyocytes. Conclusion: The results indicate that SMS may alleviate diabetes-induced myocardial hypertrophy and diastolic dysfunction by improving mitochondrial lipid metabolism.


Author(s):  
Ying Han ◽  
Hui Sun ◽  
Aihua Zhang ◽  
Fangfang Wu ◽  
Wenfeng Wei ◽  
...  

2017 ◽  
Vol 8 (4) ◽  
pp. 1660-1671 ◽  
Author(s):  
Shengwen Lu ◽  
Ying Han ◽  
Hang Chu ◽  
Ling Kong ◽  
Aihua Zhang ◽  
...  

Metabolomics approach describing the nervous protective mechanism of Shengmai-San (SMS) in Alzheimer's disease (AD).


Sign in / Sign up

Export Citation Format

Share Document